Login/Sign Up
In a 78-year-old male patient experiencing a recurrence of fever and fatigue post-transarterial chemoembolization (TACE) after discontinuing a 10-day course of dexamethasone, is it safe and clinically appropriate to resume low-dose dexamethasone (1 mg/day) for an additional 10 to 15 days, and what are the primary considerations for managing recurrent post-TACE syndrome?
In a 78-year-old male patient experiencing a recurrence of fever and fatigue post-transarterial chemoembolization (TACE) after discontinuing a 10-day course of dexamethasone, is it safe and clinically appropriate to resume low-dose dexamethasone (1 mg/day) for an additional 10 to 15 days, and what are the primary considerations for managing recurrent post-TACE syndrome?
Answered 10 days ago